These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25049157)

  • 1. New oral anticoagulants for non-valvular atrial fibrillation: harder to handle than expected.
    Shurlock B
    Eur Heart J; 2014 Jul; 35(28):1825-36. PubMed ID: 25049157
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.
    Lip GY; Bongiorni MG; Dobreanu D; Lewalter T; Hastrup Svendsen J; Blomström-Lundqvist C;
    Europace; 2013 Oct; 15(10):1526-32. PubMed ID: 24072770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [As cardiologists how much do we take into account the guideline recommendations while prescribing oral anticoagulants to patients with atrial fibrillation our clinical practice? A striking result!].
    Ertaş F
    Anadolu Kardiyol Derg; 2013 Nov; 13(7):726-7. PubMed ID: 24172806
    [No Abstract]   [Full Text] [Related]  

  • 4. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Heart Rhythm Association launches a practical guide on new oral anticoagulants in atrial fibrillation.
    Taylor J
    Eur Heart J; 2013 Mar; 34(11):791. PubMed ID: 23492939
    [No Abstract]   [Full Text] [Related]  

  • 6. Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?
    Foley J; Lip GY
    Int J Clin Pract; 2012 May; 66(5):422-4. PubMed ID: 22512602
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor Xa inhibitors: a step forward in the treatment of atrial fibrillation?
    Algra A
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):ED000064. PubMed ID: 24156099
    [No Abstract]   [Full Text] [Related]  

  • 8. An audit of two methods of anticoagulation monitoring in a general practice.
    Wright KR
    J Prim Health Care; 2010 Dec; 2(4):318-22. PubMed ID: 21125073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to using warfarin in non-valvular atrial fibrillation.
    Gattellari M; Worthington JM; Zwar NA; Middleton S
    BMJ; 2006 Feb; 332(7536):303-4. PubMed ID: 16455738
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
    Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin in non-valvular atrial fibrillation.
    Dalby AJ; Wessels P; Opie LH
    S Afr Med J; 2013 Oct; 103(12):901-4. PubMed ID: 24300625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe--a multicentric evaluation.
    Luger S; Hohmann C; Kraft P; Halmer R; Gunreben I; Neumann-Haefelin T; Kleinschnitz C; Walter S; Haripyan V; Steinmetz H; Foerch C; Pfeilschifter W
    Int J Stroke; 2014 Jul; 9(5):569-75. PubMed ID: 24828272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin for stroke prevention in atrial fibrillation: time to switch?
    Ahmad Y; Lip GY
    Int J Clin Pract; 2013 Jul; 67(7):603-5. PubMed ID: 23758442
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Potpara TS; Lip GY; Dagres N; Estner HL; Larsen TB; Blomström-Lundqvist C;
    Europace; 2014 Feb; 16(2):293-8. PubMed ID: 24478291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the benefit of the novel oral anticoagulant agents in patients with non-valvular atrial fibrillation.
    Patti G; Cavallari I
    Intern Emerg Med; 2015 Apr; 10(3):395-6. PubMed ID: 25487959
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.
    Alberts MJ; Eikelboom JW; Hankey GJ
    Lancet Neurol; 2012 Dec; 11(12):1066-81. PubMed ID: 23153406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New oral anticoagulants for non-valvular atrial fibrillation--safety issues.
    Barry M
    Ir Med J; 2013 Mar; 106(3):69. PubMed ID: 23951972
    [No Abstract]   [Full Text] [Related]  

  • 20. There is a need for independent studies about new oral anticoagulants in atrial fibrillation patients.
    Stöllberger C; Schneider B; Finsterer J
    Int J Cardiol; 2014; 172(1):e119-20. PubMed ID: 24439870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.